CRIDO advised Dr. Irena Eris S.A. on the acquisition of a 100% stake in Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Exim Sp. z o.o.

13 January 2023
3 min

CRIDO's interdisciplinary team of corporate finance and financial due diligence experts, lawyers, and tax advisors provided comprehensive support for the Dr Irena Eris Group in the acquisition of a 100% stake in Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Exim Sp. z o.o.

The expansion of the Dr Irena Eris Group by Sulphur is yet another step on the path to implementing the Group’s business strategy that involves increasing the scale of operations through, among other things, acquiring pharmaceutical and cosmetics targets. Sulphur’s previous owners decided to sell 100% shares in their company to the Dr Irena Eris Group.

CRIDO’s team was responsible for ongoing Corporate Finance consulting for the buyer, supporting the legal, tax, and financial due diligence of the target, and providing comprehensive legal and tax consulting in the course of negotiating transaction documentation.

CRIDO’s team involved in the transaction included: Artur Marszałkiewicz (Managing Partner), Aleksandra Małolepsza (Senior Associate), and Monika Olak (Senior Financial Analyst) from the Corporate Finance team; Przemysław Furmaga (Partner and Head of M&A), Aleksandra Czarnecka (Senior Associate), Andrzej Dunikowski (Senior Associate), and Michał Tokarz (Junior Associate) from the Legal Advisory team; Mateusz Stańczyk (Partner, M&A team), Małgorzata Piłat (Senior Manager), Michalina Opoka (Manager), Maciej Dybaś (Partner), and Jędrzej Golatowski (Manager) from the Tax Advisory team; and Jacek Ostrowski (Partner, M&A team), Monika Tatar (Senior Manager), and Karolina Hofman (Senior Consultant) from the Financial Advisory team.

“CRIDO's transaction consulting team assisted us throughout the process of acquiring shares in Sulphur. With good communication and the full commitment of both parties, the transaction was finalised very quickly. We are very pleased to welcome the Sulphur team to the Dr Irena Eris Group in the beginning of 2023,”  says Paweł Orfinger, CEO, Dr. Irena Eris S.A.

It is a great pleasure for us that we could provide comprehensive support for our client, offering advice on all transactional aspects, and thus contribute to the growth and expansion of the Dr Irena Eris Group. This holistic approach allows us to generate added value for the client, who receives full support at a one-stop shop,” comments Artur Marszałkiewicz, Managing Partner, M&A Team, Corporate Finance, CRIDO.

CRIDO supports entrepreneurs, corporations, and PE/VC funds in domestic and foreign M&A transactions, assisting them in their transactions every step of the way. CRIDO's consulting services include tax and financial due diligence, Corporate Finance, and comprehensive legal support, including legal due diligence.

CRIDO’s Corporate Finance team provides comprehensive transactional consulting in the M&A process. It also supports our Clients in obtaining financing for implementing acquisition, expansion and investment, and project finance undertakings alike. In this respect, we collaborate with banks, private equity funds, and specialised funds.